"The United States Food and Drug Administration (FDA) is working collaboratively with interventional radiologists and it could lead to prostatic artery embolization (PAE) becoming part of standard of care for treating BPH (benign prostatic hyperplasia) within the next 3 - 7 years" according to Riad Salem, MD, MBA who is Professor of Radiology, Medicine and Surgery Vice-Chairman, Image-Guided Therapy Chief, Vascular and Interventional Radiology at Northwestern University, Chicago, Illinois.
"Dr Salem said there is compelling evidence for performing PAE for BPH. He noted that there has been proof of concept as well as technical reviews and studies that have been reproducible. "We believe in it and we think in the next 3 - 7 years PAE will become part of the standard of care", said Dr Salem.
"He said there is a clear unmet medical need that can be addressed through PAE. he also noted the simplicity of technique. However he noted it is important to validate international groups and establish PAE for BPH through rigorous testing.
You can read the full article here